Could an antidepressant be better at treating Covid-19 than Merck's new, expensive pill? Plus, lots of pushback from parents expected as vaccines are approved for younger kids.  episode artwork

EPISODE · Oct 27, 2021 · 18 MIN

Could an antidepressant be better at treating Covid-19 than Merck's new, expensive pill? Plus, lots of pushback from parents expected as vaccines are approved for younger kids.

from The On Deadline Podcast

New research shows that a widely available antidepressant could be even more effective than a new pill from Merck at treating Covid-19. And it's much less expensive.Speaking of that pill, Merck will allow a nonprofit group to manufacture it for low and middle income countries. But it won't allow for a generic option.The FDA is expected to give final approval to Pfizer's vaccine for 5 to 11 year old kids later this week. How much resistance will we see from parents?Yet another thing made worse by the pandemic: Childhood obesity. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Episode metadata supplied by the publisher feed · Published Oct 27, 2021

Embed this episode

Ready to play

Could an antidepressant be better at treating Covid-19 than Merck's new, expensive pill? Plus, lots of pushback from parents expected as vaccines are approved for younger kids.

0:00 18:34

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The On Deadline Podcast?

This episode is 18 minutes long.

When was this The On Deadline Podcast episode published?

This episode was published on October 27, 2021.

Can I download this The On Deadline Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!